The Matrix Metalloproteinase-9 Gene Polymorphisms as Risk Factor for Pelvic Organ Prolapse in Balinese Women
Kadek Ary Widayana, I Gede Mega Putra, Tjok Gde Agung Suwardewa, I Nyoman Bayu Mahendra, Anak Agung Gede Putra Wiradnyana
Keywords :
Matrix metalloproteinase-9, Pelvic organ prolapses, Polymorphism
Citation Information :
Widayana KA, Putra IG, Suwardewa TG, Mahendra IN, Wiradnyana AA. The Matrix Metalloproteinase-9 Gene Polymorphisms as Risk Factor for Pelvic Organ Prolapse in Balinese Women. J South Asian Feder Obs Gynae 2023; 15 (1):65-70.
Aim: Pelvic organ prolapse (POP), although not life-threatening, is a serious condition that can affect a patient's quality of life. As life expectancy rises, the number of women with POP continues to rise. The weakness of the pelvic floor is always found underlying each case of POP. This weakness in the pelvic floor is associated with repeated damage to muscles and connective tissue due to the process during pregnancy and delivery. Balinese women have risk factors for developing POP related to the obligation to continue their offspring by conceiving and giving birth more than 4 times and working as heavy workers. The presence of genetic factors is also thought to play a role as a risk factor for POP in Balinese women. The purpose of this study was to prove the existence of polymorphism matrix metalloproteinase-9 (MMP-9) rs17576 as a factor that puts Balinese women at risk for POP.
Materials and methods: A paired case–control study was conducted on each of 30 Balinese women with POP and without prolapse, which was done matching based on parity and occupation variables at Sanglah Hospital, Denpasar and Integrated Biomedical Laboratory, Faculty of Medicine, Udayana University. The EDTA tube contains 3 milliliters of venous blood, from which the sample material is taken. DNA isolation, PCR, and sequencing examinations were performed to determine the presence of MMP-9 rs17576 gene polymorphism.
Results: Balinese women's POP risk was quadrupled by the gene polymorphism of the MMP-9 rs17576 genotype AG compared to without prolapse (OR = 4.00, 95% CI 1.13–14.18, p = 0.04).
Conclusion: In Balinese women, the presence of MMP-9 rs17576 gene polymorphism raises the risk of POP.
Haylen BT, Maher CF, Barber MD, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Int Urogynecol J 2016;27(2):165–194. DOI: 10.1007/s00192-015-2932-1.
Barber MD. Pelvic organ prolapse. BMJ 2016;354:i3853. DOI: 10.1136/bmj.i3853.
Walker GJA, Gunasekera P. Pelvic organ prolapse and incontinence in developing countries: Review of prevalence and risk factors. Int Urogynecol J 2011;22(2):127–135. DOI: 10.1007/s00192-010-1215-0.
Mega Putra G, Bagus I, Manuaba A, et al. The role of estrogen receptor α, COL3A1, and fibulin-5 genes polymorphisms as risk factors for pelvic organ prolapse in Balinese women. Gineco.eu. 2018;14(4):135–140.
Word RA, Pathi S, Schaffer JI. Pathophysiology of pelvic organ prolapse. Obstet Gynecol Clin N Am 2009;36(3):521–539. DOI: 10.1016/j.ogc.2009.09.001.
Wibisono J, Hermawan G. Prolaps organ panggul. Medicinus 2019;7(1):27. DOI: 10.19166/med.v7i1.1444.
Wu MP. Regulation of extracellular matrix remodeling associated with pelvic organ prolapse. J Exp Clin Med 2010;2(1):11–16. DOI: 10.1016/S1878-3317(10)60003-4.
Leppert PC. Tissue remodeling in the female reproductive tract–a complex process becomes more complex: The role of Hox genes. Biol Reprod 2012;86(4):98. DOI: 10.1095/biolreprod.112.099283.
Vu TH, Werb Z. Matrix metalloproteinases: Effectors of development and normal physiology. Genes Dev 2000;14(17):2123–2133. DOI: 10.1101/gad.815400.
Verma RP, Hansch C. Matrix metalloproteinases (MMPs): Chemical– biological functions and (Q)SARs. Bioorg Med Chem 2007;15(6):2223–2268. DOI: 10.1016/j.bmc.2007.01.011.
Gong R, Xia Z. Collagen changes in pelvic support tissues in women with pelvic organ prolapse. Eur J Obstet Gynecol Reprod Biol 2019;234:185–189. DOI: 10.1016/j.ejogrb.2019.01.012.
Wang X, Li Y, Chen J, et al. Differential expression profiling of matrix metalloproteinases and tissue inhibitors of metalloproteinases in females with or without pelvic organ prolapse. Mol Med Rep 2014;10(4):2004–2008. DOI: 10.3892/mmr.2014.2467.
Swetha R, Gayen C, Kumar D, et al. Biomolecular basis of matrix metallo proteinase-9 activity. Future Med Chem 2018;10(9):1093–1112. DOI: 10.4155/fmc-2017-0236.
Budatha M, Roshanravan S, Zheng Q, et al. Extracellular matrix proteases contribute to progression of pelvic organ prolapse in mice and humans. J Clin Investig 2011;121(5):2048–2059. DOI: 10.1172/JCI45636.
Lim VF, Khoo JK, Wong V, et al. Recent studies of genetic dysfunction in pelvic organ prolapse: The role of collagen defects. Aust NZJ Obstet Gynaecol 2014;54(3):198–205. DOI: 10.1111/ajo.12169.
Fanjul-Fernández M, Folgueras AR, Cabrera S, et al. Matrix metalloproteinases: Evolution, gene regulation and functional analysis in mouse models. Biochim Biophys Acta 2010;1803(1):3–19. DOI: 10.1016/j.bbamcr.2009.07.004.
Chen H-Y, Lin W-Y, Chen Y-H, et al. Matrix metalloproteinase-9 polymorphism and risk of pelvic organ prolapse in Taiwanese women. Eur J Obstet Gynecol Reprod Biol 2010;149(2):222–224. DOI: 10.1016/j.ejogrb.2009.12.014.
Wu JM, Visco AG, Grass EA, et al. Matrix metalloproteinase-9 genetic polymorphisms and the risk for advanced pelvic organ prolapse. Obstet Gynecol 2012;120(3):587–593. DOI: 10.1097/AOG.0b013e318262234b.
Ghersel FR, Souto RP, Gonzales EWP, et al. Assessment of metalloproteinase matrix 9 (MMP9) gene polymorphisms risk factors for pelvic organ prolapse in the Brazilian population. Rev Bras Ginecol Obstet 2019;41(3):164–169: DOI: 10.1055/s-0039-1681112.
Ferrari MM, Rossi G, Biondi ML, et al. Type I collagen and matrix metalloproteinase 1, 3 and 9 gene polymorphisms in the predisposition to pelvic organ prolapse. Arch Gynecol Obstet 2012;285(6):1581–1586. DOI: 10.1007/s00404-011-2199-9.
Sudantra IK. Wanita Bali dan harta benda perkawinan: Suatu perspektif normatif 2002;2(2):79–87.
Windiyarti D. Pemberontakan perempuan Bali terhadap diskriminasi kelas dan gender: Kajian feminis novel tarian bumi karya Oka Rusmini. J Humaniora 2012;20(3):286–294. DOI: 10.22146/jh.945.
Swift S, Woodman P, O'Boyle A, et al. Pelvic Organ Support Study (POSST): The distribution, clinical definition, and epidemiologic condition of pelvic organ support defects. Am J Obstet Gynecol 2005;192(3):795–806. DOI: 10.1016/j.ajog.2004.10.602.
Vergeldt TFM, Weemhoff M, IntHout J, et al. Risk factors for pelvic organ prolapse and its recurrence: A systematic review. Int Urogynecol J 2015;26(11):1559–1573. DOI: 10.1007/s00192-015-2695-8.
Huang L, Zhao Z, Wen J, et al. Cellular senescence: A pathogenic mechanism of pelvic organ prolapse (Review). Mol Med Rep 2020;22(3):2155–2162. DOI: 10.3892/mmr.2020.11339.
Sharma G, Parulekar SV. Accuracy of clinical evaluation of patients with site-specific vaginal wall prolapse and its corelation to surgical diagnosis. J South Asian Fed Obstet Gynaecol 2015;10(3):175–181. DOI: 10.5005/jp-journals-10006-1584.
Lukacz ES, Lawrence JM, Contreras R, et al. Parity, mode delivery, and pelvic floor disorders. Obstet Gynecol 2006;107(6):1253–1260. DOI: 10.1097/01.AOG.0000218096.54169.34.
Nygaard IE, Shaw JM. Physical activity and the pelvic floor. Am J Obstet Gynecol 2016;214(2):164–171. DOI: 10.1016/j.ajog.2015.08.067.
Nygaard IE, Shaw JM, Bardsley T, et al. Lifetime physical activity and pelvic organ prolapse in middle-aged women. Am J Obstet Gynecol 2014;210(5):477.e1–477.e12. DOI: 10.1016/j.ajog.2014.01.035.
Garg M, Sharma R, Banerjee BD, et al. Association of HOXA13 gene expression among premenopausal women with the severity of pelvic organ prolapse: A cross-sectional study. J South Asian Fed Obstet Gynaecol 2022;14(4):420–423. DOI: 10.5005/jp-journals-10006-2079.
Giri A, Hartmann KE, Hellwege JN, et al. Obesity and pelvic organ prolapse: A systematic review and meta-analysis of observational studies. Am J Obstet Gynecol 2017;217(1):11–26.e3. DOI: 10.1016/j.ajog.2017.01.039.
Rahmatyah R, Hardiyanto G, Susanti D. Correlation between pelvic organ prolapse symptoms and age of menopause. Majalah Obstet Ginekol 2017;25(1):30–32. DOI: 10.20473/mog.V25I12017.30-32.
Zhou L, Shangguan AJ. Estrogen and pelvic organ prolapse. J Mol Genet Med 2016;10(2). DOI: 10.4172/1747-0862.1000221.
Blandon RE, Bharucha AE, Melton LJ, et al. Incidence of pelvic floor repair after hysterectomy. Am J Obstet Gynecol 2007;197(6):664.e1–664.e7. DOI: 10.1016/j.ajog.2007.08.064.
Lee C-Y, Tseng C-J, Chang C-H, et al. Effect of modified laparoscopic hysterectomy on pelvic floor function: A retrospective observational study. Medicine 2019;98(8):e14616. DOI: 10.1097/MD.0000000000014616.
Vandooren J, Van den Steen PE, Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): The next decade. Crit Rev Biochem Mol Biol 2013;48(3):222. DOI: 10.3109/10409238.2013.770819.
Wu H, Bai X, Chen D, et al. Association of genetic polymorphisms in matrix metalloproteinase-9 and coronary artery disease in the Chinese Han population: A case–control study. Genet Test Mol Biomarkers 2013;17(9):707–712. DOI: 10.1089/gtmb.2013.0109.
Huang H. Matrix metalloproteinase-9 (MMP-9) as a cancer biomarker and MMP-9 biosensors: Recent advances. Sensors 2018;18(10):3249. DOI: 10.3390/s18103249.
Kamal A, Elgengehy FT, Abd Elaziz MM, et al. Matrix metalloproteinase-9 rs17576 gene polymorphism and Behçet's disease: Is there an association? Immunol Invest 2017;46(5):460–468. DOI: 10.1080/08820139.2017.1296857.
Zou F, Zhang J, Xiang G, et al. Association of matrix metalloproteinase 9 (MMP-9) polymorphisms with asthma risk: A meta-analysis. Can Respir J 2019:9260495. DOI: 10.1155/2019/9260495.
Kerkhof MH, Hendriks L, Brölmann HAM. Changes in connective tissue in patients with pelvic organ prolapse—A review of the current literature. Int Urogynecol J Pelvic Floor Dysfunction 2009;20(4):461–474. DOI: 10.1007/s00192-008-0737-1.